Precia Pharma Private Limited, a active private limited company, was established on 14 May 2010 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MH2010PTC203201. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹4.31 Cr.
Formerly known as Precia Phama Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Anil Marotrao Pawar (Director), Sanjay Marotrao Pawar (Managing Director). Past directors included Anil Marotrao Pawar, Sajid Akhtar Rafique Ahmed Shaikh, Anup Omprakash Tapadiya. It holds ₹6.65 Cr open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Bl Dg-D-4 Flat - 502, Laxmi Narayan Residency, Pokhran Road No, . 1,, Thane, Maharashtra, 400606.
U24233MH2010PTC203201
203201
14 May 2010
₹4.50 Cr
₹4.31 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Precia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Marotrao Pawar | Director | 14 Jul 2023 | Current |
| Sanjay Marotrao Pawar | Managing Director | 14 May 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Director | 01 Aug 2011 | Past |
| Pramod Abcsdd | Director | 19 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Precia Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.05% decrease. The company also saw a substantial improvement in profitability, with a 45.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Precia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹66,500,000.00
₹8,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2023 | Others | ₹3.55 Cr | Open |
| 16 Aug 2018 | Others | ₹3.10 Cr | Open |
| 12 Sep 2017 | Tjsb Sahakari Bank Limited | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Precia Pharma has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Precia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Precia Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Precia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity A charge with Others amounted to Rs. 3.55 Cr with Charge ID 100784660 was registered on 31 Aug 2023. was completed.
The activity Anil Marotrao Pawar was appointed as a Director was appointed as a Director on 14 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
Precia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others of Rs. 3.10 Cr registered on 16 Aug 2018 with Charge ID 100197741 was modified on 19 Jul 2019. was documented.
The activity A charge registered on 12 Sep 2017 via Charge ID 100125652 with Tjsb Sahakari Bank Limited was fully satisfied on 05 Oct 2018. was completed.
The CIN of Precia Pharma Private Limited is U24233MH2010PTC203201.
Precia Pharma Private Limited is headquartered at Bl Dg-D-4 Flat - 502, Laxmi Narayan Residency, Pokhran Road No, . 1,, Thane, Maharashtra, 400606.
Precia Pharma Private Limited was incorporated on 14 May 2010.
The current directors of Precia Pharma Private Limited are
The primary industry of Precia Pharma Private Limited is Manufacturing.
Precia Pharma Private Limited is unlisted.
The authorized capital of Precia Pharma Private Limited is ₹4.50 Cr, and the paid-up capital is ₹4.31 Cr.
The compliance status of Precia Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX